MDB TEXINOV

MDB Texinov specialises in meshed textile-based medical devices. Their portfolio includes surgical drapes like the Texishield F2-B IIR and Texishield CH-B02, which are used to maintain sterile fields during procedures. They also produce wound care products such as the Texlight 6V1 and Texlight 2V1, designed to support healing environments. Additionally, the company offers fluid management systems, including the FLUXMED variants (e.g., FLUXMED 1V1, FLUXMED 4V2) for drainage and absorption, as well as a drainage cap (Cap 2) and a fluid management pad (FMP 03).

MDB Texinov is based in France, which means its medical devices are subject to EU Medical Device Regulations (MDR) or In Vitro Diagnostic Regulation (IVDR) depending on the device type. Since the company’s devices are listed in the EU’s eudamed database, this confirms they comply with mandatory EU registration requirements. The French location also aligns with the EU’s regulatory framework, ensuring devices meet safety, performance, and traceability standards before entering the market.

MDB Texinov’s medical devices are registered in the eudamed database, the official EU portal for medical device information. This database is maintained by the European Medicines Agency (EMA) and is required for transparency and traceability under EU Medical Device Regulations. Listing in eudamed confirms the manufacturer’s compliance with EU registration obligations, allowing devices to be legally marketed within the European Economic Area.

MDB Texinov’s devices are classified as Class I or Class IIa under EU Medical Device Regulations. Classification determines the regulatory requirements for each device, such as risk assessment, clinical evaluation, and post-market surveillance. Class I devices generally pose lower risks and may require less stringent documentation, while Class IIa devices involve moderate risks and require additional evidence of safety and performance. The classification ensures appropriate oversight based on the device’s potential harm to patients.

The provided data only confirms that MDB Texinov’s devices are registered in the EU’s eudamed database, which applies to the European Economic Area (EEA). Whether these devices are authorised or marketed outside the EU (e.g., in the UK, Switzerland, or non-EU countries) depends on local regulatory pathways and compliance with those jurisdictions’ requirements. The company’s classification and registration status in the EU do not automatically extend to other markets.